Elisabeth M. Davis
Role not yet determined Is this you? Add your title
Also affiliated: Dalhousie University (2007–2010); University of Alberta (2008–2015); University of Calgary (2015); Izaak Walton Killam Health Centre (2010); Central Arkansas Veterans Healthcare System (2015–2016); Canadian Centre for Vaccinology (2010)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Elisabeth M. Davis's research has focused on the study of intestinal mucosal immunopathology and its association with specific genetic conditions. Her work has investigated the role of epithelial cell extrusion in intestinal barrier integrity and explored biomarkers for predicting treatment response in inflammatory bowel diseases like Crohn's. Davis has also examined the mechanisms of pyroptosis, a form of programmed cell death, in the context of functional dyspepsia, utilizing confocal laser endomicroscopy and ex vivo analysis. Her publications include research on the immunopathology of hereditary alpha-tryptasemia and the relationship between mucosal biomarkers and vedolizumab efficacy in Crohn's disease patients. Davis's scholarship metrics include an h-index of 14, with 36 total publications and 501 total citations.
Metrics
- h-index: 13
- Publications: 31
- Citations: 410
Selected Publications
-
Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia (2021)
-
Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease (2020)
-
Evidence of Duodenal Epithelial Barrier Impairment and Increased Pyroptosis in Patients With Functional Dyspepsia on Confocal Laser Endomicroscopy and “Ex Vivo” Mucosa Analysis (2020)
-
Epithelial cell biomarkers are predictive of response to biologic agents in Crohn’s disease (2020)
-
734 Colonic Biopsy Pyroptosis Predicts Clinical Response to Vedolizumab in Crohn's Disease (2019)
-
Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn’s Disease (2019)
-
Epithelial Cell Extrusion Zones Observed on Confocal Laser Endomicroscopy Correlates with Immunohistochemical Staining of Mucosal Biopsy Samples (2016)
-
A Pilot Study of Confocal Laser Endomicroscopy to Predict Barrier Dysfunction and Relapse in Pediatric Inflammatory Bowel Disease (2015)
-
Peptide-Mediated PEGylation of Polysulfone Reduces Protein Adsorption and Leukocyte Activation (2015)
Collaboration Network
Top Collaborators
- Evidence of Duodenal Epithelial Barrier Impairment and Increased Pyroptosis in Patients With Functional Dyspepsia on Confocal Laser Endomicroscopy and “Ex Vivo” Mucosa Analysis
- Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn’s Disease
- A Pilot Study of Confocal Laser Endomicroscopy to Predict Barrier Dysfunction and Relapse in Pediatric Inflammatory Bowel Disease
- Epithelial Cell Extrusion Zones Observed on Confocal Laser Endomicroscopy Correlates with Immunohistochemical Staining of Mucosal Biopsy Samples
- Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease
Showing 5 of 7 shared publications
- Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn’s Disease
- A Pilot Study of Confocal Laser Endomicroscopy to Predict Barrier Dysfunction and Relapse in Pediatric Inflammatory Bowel Disease
- Epithelial Cell Extrusion Zones Observed on Confocal Laser Endomicroscopy Correlates with Immunohistochemical Staining of Mucosal Biopsy Samples
- Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease
- Epithelial cell biomarkers are predictive of response to biologic agents in Crohn’s disease
Showing 5 of 6 shared publications
- Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia
- Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn’s Disease
- Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease
- Epithelial cell biomarkers are predictive of response to biologic agents in Crohn’s disease
- 734 Colonic Biopsy Pyroptosis Predicts Clinical Response to Vedolizumab in Crohn's Disease
- Evidence of Duodenal Epithelial Barrier Impairment and Increased Pyroptosis in Patients With Functional Dyspepsia on Confocal Laser Endomicroscopy and “Ex Vivo” Mucosa Analysis
- Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn’s Disease
- Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease
- Epithelial cell biomarkers are predictive of response to biologic agents in Crohn’s disease
- 734 Colonic Biopsy Pyroptosis Predicts Clinical Response to Vedolizumab in Crohn's Disease
- Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn’s Disease
- Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease
- Epithelial cell biomarkers are predictive of response to biologic agents in Crohn’s disease
- 734 Colonic Biopsy Pyroptosis Predicts Clinical Response to Vedolizumab in Crohn's Disease
- Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn’s Disease
- Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease
- Epithelial cell biomarkers are predictive of response to biologic agents in Crohn’s disease
- 734 Colonic Biopsy Pyroptosis Predicts Clinical Response to Vedolizumab in Crohn's Disease
- Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn’s Disease
- Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease
- Epithelial cell biomarkers are predictive of response to biologic agents in Crohn’s disease
- 734 Colonic Biopsy Pyroptosis Predicts Clinical Response to Vedolizumab in Crohn's Disease
- Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn’s Disease
- Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease
- Epithelial cell biomarkers are predictive of response to biologic agents in Crohn’s disease
- 734 Colonic Biopsy Pyroptosis Predicts Clinical Response to Vedolizumab in Crohn's Disease
- Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn’s Disease
- Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease
- Epithelial cell biomarkers are predictive of response to biologic agents in Crohn’s disease
- 734 Colonic Biopsy Pyroptosis Predicts Clinical Response to Vedolizumab in Crohn's Disease
- Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn’s Disease
- Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease
- Epithelial cell biomarkers are predictive of response to biologic agents in Crohn’s disease
- 734 Colonic Biopsy Pyroptosis Predicts Clinical Response to Vedolizumab in Crohn's Disease
- Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn’s Disease
- Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease
- Epithelial cell biomarkers are predictive of response to biologic agents in Crohn’s disease
- 734 Colonic Biopsy Pyroptosis Predicts Clinical Response to Vedolizumab in Crohn's Disease
- Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease
- Epithelial cell biomarkers are predictive of response to biologic agents in Crohn’s disease
- 734 Colonic Biopsy Pyroptosis Predicts Clinical Response to Vedolizumab in Crohn's Disease
- Epithelial Cell Extrusion Zones Observed on Confocal Laser Endomicroscopy Correlates with Immunohistochemical Staining of Mucosal Biopsy Samples
- Peptide-Mediated PEGylation of Polysulfone Reduces Protein Adsorption and Leukocyte Activation
- Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn’s Disease
- 734 Colonic Biopsy Pyroptosis Predicts Clinical Response to Vedolizumab in Crohn's Disease
- Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease
- Epithelial cell biomarkers are predictive of response to biologic agents in Crohn’s disease
Similar Researchers
Based on overlapping research topics